comparemela.com

Page 5 - Noreen Fraser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VETERAN FUNDRAISING EXECUTIVE STEPHANIE HERRON JOINS SU2C AS CHIEF DEVELOPMENT OFFICER

LOS ANGELES (August 15, 2022) – Stand Up To Cancer® (SU2C) today announced the appointment of Stephanie Herron as its first Chief Development Officer.

United statesLisa paulsenKatie couricEllen ziffrenKathleen lobbNoreen fraserSherry lansingLaura ziskinStephanie herronFiona mcrobertAdvisors committeeDevelopment officerEntertainment industry foundationScientific advisory committeeTexasam universityJude children research hospital

AMERICAN AIRLINES PUSHING CANCER RESEARCH TO NEW HEIGHTS WITH FUNDRAISING CAMPAIGN

/PRNewswire/ American Airlines, in collaboration with Stand Up To Cancer (SU2C) and Emmy, Grammy and Golden Globe-nominated actress, singer and songwriter.

United statesLisa paulsenKatie couricEllen ziffrenKathleen lobbAaron defeoNoreen fraserSherry lansingLaura ziskinMandy moorePrnewswire american airlinesAmerican airlines aadvantage mastercardCancer coAmerican airlines aadvantageAmerican airlines groupAmerican airlines

STAND UP TO CANCER ANNOUNCES $5 MILLION SPONSORSHIP FROM JANSSEN IN SUPPORT OF INITIATIVE TO IMPROVE HEALTH EQUITY IN CLINICAL TRIALS

/PRNewswire/ Today Stand Up To Cancer® (SU2C) announced a sponsorship from the Janssen Pharmaceutical Companies of Johnson & Johnson aimed at increasing.

United statesLisa paulsenKatie couricEllen ziffrenJeffrey infanteKathleen lobbNoreen fraserSherry lansingLaura ziskinDiversity in early development clinical trials programHealth centersC health equity initiativeDrug administrationOncology early clinical developmentJanssen research developmentJanssen pharmaceutical companies of johnson

STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO FUND TARGETED CANCER THERAPY RESEARCH

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesSan diegoLisa paulsenAnthony sunKatie couricEllen ziffrenKathleen lobbNoreen fraserSherry lansingLos angelesLaura ziskinLee helmanC scientific advisory committeeBlood disease instituteZentalis pharmaceuticals inc

STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO FUND TARGETED CANCER THERAPY RESEARCH

Funds Will Support the SU2C Catalyst program and the Study of Small Molecule Inhibitors for Treating CancerLOS ANGELES, March 15, 2022 /PRNewswire.

United statesNew yorkSan diegoLisa paulsenAnthony sunKatie couricEllen ziffrenKathleen lobbNoreen fraserSherry lansingLos angelesLaura ziskinLee helmanC scientific advisory committeeBlood disease instituteZentalis pharmaceuticals inc

vimarsana © 2020. All Rights Reserved.